Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) is a once-weekly injection, and it can be taken at any time of day, with or without food. Unlike the oral Wegovy tablet, the injection form has no food-timing restriction — you do not need to fast beforehand or wait after eating. That said, a few practical habits around your chosen injection day can make the experience more comfortable. These are prescription-only medicines and must be prescribed following a clinical assessment; what feels right for your routine is something a prescriber can discuss with you. If you're curious about the basics of who Wegovy suits and how it works, that's a good place to start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
For the weekly subcutaneous injection, the short answer is no. The semaglutide in Wegovy goes directly into fatty tissue under the skin (typically the abdomen, thigh or upper arm) so what's in your stomach at that moment has no bearing on how much reaches your bloodstream. The NHS patient information for semaglutide confirms there are no food-timing requirements for the injection form.
What does matter is that you pick a day and, broadly, a time of week that you can stick to. Consistency keeps your drug levels even. Some people tie it to a Sunday morning before the week gets busy; others find a weekday evening easier. Neither is better medically, the right one is whichever you'll remember.
Rotating your injection site is more important than timing relative to food. Using the same spot repeatedly can cause a small hardened area under the skin that affects absorption. Abdomen, thigh and upper arm all work; a small circular rota across these sites is the habit worth building. Your Patient Information Leaflet gives the full guidance, and the Wegovy overview page covers what to expect from each stage of treatment.
Because Wegovy slows gastric emptying, food moves through the stomach more slowly than usual. That's part of how it reduces appetite, but it also means a large, fatty or rich meal can sit heavily and amplify nausea, particularly in the early weeks of treatment or just after a dose increase.
This is not a timing interaction in the pharmacological sense; it's more a comfort consideration. Most people who experience injection-day nausea find that smaller portions, plainer foods and staying upright for a while after eating help considerably. It usually settles within a couple of weeks as the body adjusts. The side-effect profile of semaglutide (including nausea, vomiting, constipation and indigestion) is well documented on the NHS semaglutide medicines page.
If nausea is persistent or severe, that is worth raising with your prescriber before the next dose increase rather than pushing through. Adjusting the titration schedule is a legitimate clinical tool, not a failure. For related questions about what you can do around injection day, the guide on bathing and activity after your shot covers the practical side.
Yes, completely. The oral Wegovy tablet uses an absorption technology that requires the stomach to be empty and the environment to be as close to neutral as possible. The recommended routine is to take it first thing in the morning with a small amount of plain water (no more than around 120ml) then wait at least 30 minutes before eating, drinking anything other than water, or taking any other oral medicines. Think of it as the tablet going in before the kettle even goes on.
Missing that window meaningfully reduces absorption. Coffee, juice, food and most other medicines all interfere, which is why the 30-minute gap is fixed, not approximate. The 25mg maintenance dose (reached through a slow escalation from 1.5mg) was approved by the MHRA in June 2026 as the first oral GLP-1 weight-management medicine licensed in the UK. Full dosing detail is in the Patient Information Leaflet, and the broader question of semaglutide and food timing explores this across both formulations.
If you are already established on the injection and considering a switch to the tablet, that requires a prescriber assessment, it is not a straightforward swap. The treatment options page explains what's available and how the consultation process works.
Alcohol is not a blanket contraindication for the Wegovy injection, but it is worth approaching with care, particularly in the early weeks. Alcohol can worsen nausea, and there are interactions worth understanding, the guide on Wegovy and alcohol goes into the details.
Hydration generally matters more than food timing. Wegovy can reduce thirst alongside appetite, and people who experience vomiting or diarrhoea (especially early in treatment) can become dehydrated more quickly than they expect. Sipping water throughout the day, even when you don't feel thirsty, is a habit that the NHS endorses broadly for anyone on GLP-1 treatment.
A final practical note: if you're thinking about the cost of treatment alongside all of this, what Wegovy costs privately in the UK is worth reading before assuming a figure. For now, if you'd like a prescriber to assess whether Wegovy suits your circumstances, speaking to our prescribers is straightforward, free to start, and reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.